CBIZ INSURANCE SERVICES, INC. – Trademark Portfolio
Entity Type: 03
CBIZ INSURANCE SERVICES, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MCRAIL, SLATON, PAY AS YOU PLAY, and MCRAIL A BORDEN PERLMAN CO. The owner is based in CUMBERLAND, MD.
44 BALTIMORE STREET
CUMBERLAND, MD 21502
Showing of trademarks Trademarks
Trademark Classifications
CBIZ INSURANCE SERVICES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CBIZ INSURANCE SERVICES, INC. have?
CBIZ INSURANCE SERVICES, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 cancelled.
What trademark classes does CBIZ INSURANCE SERVICES, INC. file in?
CBIZ INSURANCE SERVICES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are CBIZ INSURANCE SERVICES, INC.'s most well-known trademarks?
CBIZ INSURANCE SERVICES, INC.'s registered trademark portfolio includes well-known marks such as MCRAIL, SLATON, PAY AS YOU PLAY, and MCRAIL A BORDEN PERLMAN CO. These are among 4 currently registered trademarks in the portfolio.
What is CBIZ INSURANCE SERVICES, INC.'s trademark registration success rate?
CBIZ INSURANCE SERVICES, INC. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.